Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
141 hedge funds and large institutions have $1.25B invested in Immunogen Inc in 2013 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 8 closing their positions.
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
47% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 38
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more funds holding
Funds holding: 128 → 141 (+13)
4% more capital invested
Capital invested by funds: $1.2B → $1.25B (+$53.5M)
8% less call options, than puts
Call options by funds: $9.24M | Put options by funds: $10M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$31.3M |
| 2 |
ClearBridge Investments
New York
|
+$13.4M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$8.68M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.12M |
| 5 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$48.6M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$6.53M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.37M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.29M |
IMGN Hedge Fund Activity: Q3 2013 in Review
141 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2013, worth a combined $1.25B — up 4.5% from $1.2B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new IMGN positions and 8 closed out — a net gain of 15 holders — while 56 added to existing stakes and 38 trimmed.
The largest buyer was Norges Bank, adding an estimated $31.3M. The largest seller was Sectoral Asset Management, cutting an estimated $48.6M.
- 141 institutional investors held Immunogen Inc (IMGN) as of Q3 2013, up from 128 in Q2 2013.
- Funds reported $1.25B of Immunogen Inc stock for Q3 2013, up 4.5% quarter-over-quarter.
- 23 funds opened new Immunogen Inc positions in Q3 2013 and 8 closed out, a net change of +15 holders.
- The largest Immunogen Inc buyer in Q3 2013 was Norges Bank, an estimated $31.3M added.
- The largest Immunogen Inc seller in Q3 2013 was Sectoral Asset Management, an estimated $48.6M sold.
Based on aggregated 13F filings for Q3 2013.